Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Naturally or surgically postmenopausal~* Moderate or severe symptoms of vaginal atrophy (ie, dryness, itching, pain, uncomfortable intercourse)~Exclusion Criteria:~* Known sensitivity or contraindication to estrogens or progestins~* History or current diagnosis of endometrial hyperplasia~* Recent history of vaginal bleeding of unknown cause~* Recent history or diagnosis of endometriosis~* Any contraindication to estrogen therapy

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).